Andrei Vladimirovich Petrov
Chief Tech/Sci/R&D Officer at International Biotech Center Generium, LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anthony Cheung | M | 53 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Jason Hanson | M | 55 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 6 years |
| Richard Glickman | M | 65 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 13 years |
| Timothy J. Keiffer | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 25 years |
| Daniil Talyanskiy | M | 39 |
International Biotech Center Generium, LLC
 International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | 13 years |
| Alexander Nichols | M | 38 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 2 years |
| Dennis Langer | M | 73 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 9 years |
| Gerry Brunk | M | 55 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Steven Gannon | M | 62 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 7 years |
| Marco Boorsma | M | 49 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | - |
| Aleksandr Mikhailovich Shuster | M | 63 |
International Biotech Center Generium, LLC
International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | - |
| Andrey Georgiyevich Reus | M | 64 |
International Biotech Center Generium, LLC
International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | 12 years |
| Alexander Andryushechkin | M | 40 |
International Biotech Center Generium, LLC
International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | - |
| Maxim Valer | M | - |
International Biotech Center Generium, LLC
International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Gryska | M | 68 | 2 years | |
| John D. Menditto | M | - | 2 years | |
| Yana Robertovna Tikhonova | M | 58 |
Moscow State University Lomonosov
| 6 years |
| Brian Underdown | M | 83 | 17 years | |
| Alexey Vinogradov | M | 54 | 2 years | |
| Vladimir Karlov | M | - |
Moscow State University Lomonosov
| 5 years |
| Vladimir Vladimirovich Rykunov | M | 56 |
Moscow State University Lomonosov
| 8 years |
| Natalia Vladimirovna Opaleva | M | 55 |
Moscow State University Lomonosov
| 7 years |
| Andrzej Malec | M | 57 |
Moscow State University Lomonosov
| 4 years |
| Philippe van Holle | M | 69 | 2 years | |
| Aleksey Gennadyevich Terekhov | M | 57 |
Moscow State University Lomonosov
| 6 years |
| Anna Vasilyevna Kuznetsova | M | - |
Moscow State University Lomonosov
| 6 years |
| Eric Hsu | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 16 years |
| Sergei Dmitrievich Stanishev | M | 58 |
Moscow State University Lomonosov
| 9 years |
| Alex Fedosseev | M | - |
Moscow State University Lomonosov
| 8 years |
| Andrey Valeryevich Malikov | M | 55 |
Moscow State University Lomonosov
| 7 years |
| Denis Igorevich Korobkov | M | 57 |
Moscow State University Lomonosov
| 6 years |
| Vladimir Yuryevich Mamakin | M | 50 |
Moscow State University Lomonosov
| 7 years |
| Jean Lamarre | M | 70 | 2 years | |
| Richard D. Katz | M | 60 | 2 years | |
| Thomas Krause | M | 50 | - | |
| Dmitry Vadimovich Bakatin | M | 58 |
Moscow State University Lomonosov
| 10 years |
| Konstantin Viktorovich Garanin | M | 49 |
Moscow State University Lomonosov
| 6 years |
| Robert Carey | M | 65 | 4 years | |
| Boris I. Kovtunenko | M | - |
Moscow State University Lomonosov
| 6 years |
| Andrey Ryzhov | M | - |
Moscow State University Lomonosov
| 4 years |
| Dmitriy Andreevich Titov | M | 57 |
Moscow State University Lomonosov
| 4 years |
| Dmitry Evgenyevich Mironenkov | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Kyle Shostak | M | 53 |
Moscow State University Lomonosov
| 3 years |
| Lee Byung-Kook | M | 59 |
Moscow State University Lomonosov
| 1 years |
| Elena Gerasimovskaya | F | - |
Moscow State University Lomonosov
| 4 years |
| Kirill Neklyudov | M | 55 |
Moscow State University Lomonosov
| 4 years |
| Svyatoslav Igorevich Slavinsky | M | 54 |
Moscow State University Lomonosov
| 4 years |
| Natalia Saakyants | F | - |
Moscow State University Lomonosov
| 4 years |
| Igor Pavlovich Borovikov | M | 59 |
Moscow State University Lomonosov
| 3 years |
| Andrey Veniaminovich Reshetnikov | M | 64 |
Moscow State University Lomonosov
| 4 years |
| Mikhail Varfolomeevich Kuznetsov | M | 55 |
Moscow State University Lomonosov
| 4 years |
| Mai Huong Thi Doan | F | 56 |
Moscow State University Lomonosov
| 5 years |
| Oleg Georgievich Davidovich | M | 55 |
Moscow State University Lomonosov
| 4 years |
| Vladimir Yuryevich Skvortsov | M | 55 |
Moscow State University Lomonosov
| 4 years |
| Yelena Viktorovna Bogach | F | 48 |
Moscow State University Lomonosov
| 4 years |
| Vadim Anikeev | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Andrey Vladimirovich Drozdov | M | 51 |
Moscow State University Lomonosov
| 3 years |
| Alexey Yevtushenko | M | - |
Moscow State University Lomonosov
| 4 years |
| Sergey Ivanovich Fedorov | M | 53 |
Moscow State University Lomonosov
| 3 years |
| Andrey Markovich Uspenskiy | M | 54 |
Moscow State University Lomonosov
| - |
| Dmitry Vladimirovich Panyukov | M | 49 |
Moscow State University Lomonosov
| 4 years |
| Kirill Mikheyevich Kiosa | M | 49 |
Moscow State University Lomonosov
| 4 years |
| Slava Mazur | M | - |
Moscow State University Lomonosov
| 4 years |
| Rinat Sagidullovich Zien | M | 53 |
Moscow State University Lomonosov
| 4 years |
| Yury Slyusar | M | 49 |
Moscow State University Lomonosov
| 3 years |
| Marina Nikolayevna Tsukanova | M | 53 |
Moscow State University Lomonosov
| - |
| Natalya K. Yeryomina | F | 53 |
Moscow State University Lomonosov
| 4 years |
| Nikolay Dubik | M | 53 |
Moscow State University Lomonosov
| 3 years |
| Pavel Aleksandrovich Poselenov | M | 57 |
Moscow State University Lomonosov
| 4 years |
| Anna Viktorovna Fedorova | F | 53 |
Moscow State University Lomonosov
| 4 years |
| Dmitriy Skuratov | M | - |
Moscow State University Lomonosov
| 3 years |
| Sergey Valentinovich Solovyov | M | - |
Moscow State University Lomonosov
| 4 years |
| Dmitry Vladimirovich Konyaev | M | 53 |
Moscow State University Lomonosov
| 4 years |
| Sergey Sergeevich Skaterschikov | M | 52 |
Moscow State University Lomonosov
| 4 years |
| Vadim Viktorovich Geraskin | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Alexander Yurievich Provotorov | M | 49 |
Moscow State University Lomonosov
| 3 years |
| Ruben Karlenovich Vardanian | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Bidzina Bejuashvili | M | - |
Moscow State University Lomonosov
| 4 years |
| Larisa Gennadyevna Zelkova | F | 55 |
Moscow State University Lomonosov
| 4 years |
| Nikolai Mansurov | M | - |
Moscow State University Lomonosov
| 3 years |
| Oleg Deripaska | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Alexey V. Eliseev | M | - |
Moscow State University Lomonosov
| 4 years |
| Vladimir Vasilenko | M | 59 |
Moscow State University Lomonosov
| 3 years |
| Yulia Vladimirovna Yukhadi | F | 54 |
Moscow State University Lomonosov
| 4 years |
| Olga Naumova | F | 52 |
Moscow State University Lomonosov
| 4 years |
| Dmitry Yuryevich Olyunin | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Jun Wang | M | 59 |
Moscow State University Lomonosov
| 4 years |
| Igor Igorevich Gorskiy | M | 53 |
Moscow State University Lomonosov
| 4 years |
| Maria Vladimirovna Florenteva | F | 55 |
Moscow State University Lomonosov
| 4 years |
| Dmitry Troitsky | M | - |
Moscow State University Lomonosov
| 4 years |
| Ivan Alekseevich Novikov | M | 53 |
Moscow State University Lomonosov
| 3 years |
| Andrey Vladimirovich Nikipelov | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Vsevolod Vladimirovich Cherepanov | M | 57 |
Moscow State University Lomonosov
| 3 years |
| Sergey Sergeevich Podsypanin | M | 54 |
Moscow State University Lomonosov
| - |
| Marat Zairovich Zairov | M | 56 |
Moscow State University Lomonosov
| 4 years |
| Mikhail Alexeyevich Okunev | M | 50 |
Moscow State University Lomonosov
| 4 years |
| Margarita Aleksandrovna Loktyuhova | F | 52 |
Moscow State University Lomonosov
| 4 years |
| Batyr Alenovich Makhanbetazhiyev | M | 52 |
Moscow State University Lomonosov
| 4 years |
| Sergey Shishkin | M | 53 |
Moscow State University Lomonosov
| 3 years |
| Alexey Nikolaevich Simonov | M | 52 |
Moscow State University Lomonosov
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Russia | 81 | 81.00% |
| Canada | 10 | 10.00% |
| United States | 8 | 8.00% |
| Germany | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrei Vladimirovich Petrov
- Personal Network
